To further understand the biological consequences of the differently expressed neurotrophin receptors, TrkA and TrkB, we previously selected a Trk-negative human neuroblastoma cell line, SH-SY5Y, and designed subclones with either high TrkA or TrkB expression. The gene discussed is NTRK2; the disease is neuroblastoma.